School of Medicine
Showing 1-20 of 70 Results
-
Alexander Kaiser
Postdoctoral Research Fellow, Cardiology
Bio Alexander D. Kaiser is an applied mathematician who researches modeling and simulation of heart mechanics. His doctoral work focused on the mitral valve. He currently works in the Stanford Cardiovascular Biomechanics Computation Laboratory, led by Alison Marsden, on modeling cardiac disease.
-
Pooja Kakar
Clinical Instructor, Pediatrics - General Pediatrics
Current Research and Scholarly Interests As a breastfeeding medicine physician, I am passionate about advocating for mother-infant dyads and supporting their breastfeeding journeys. Additionally, I am interested studying and addressing disparities in initiation and duration of breastfeeding, particularly in lower-resourced populations, by building and advancing community partnerships.
I am also interested in the use of digital health tools to advance upstream determinants of health in community-based settings. My current funded research projects include: 1) Providing a telehealth-based, weight control program to children with obesity from lower-income, racial and ethnic minority families (Gardner GOALS) and 2) Assessing and addressing disparities in healthy behaviors in families from under-resourced settings through the use of a secure, multilingual mobile neighborhood app (Our Voice: Beyond Clinic Walls). -
Jennifer Kang
Academic Prog Prof 2, Pediatrics - Infectious Diseases
Current Role at Stanford Program Manager, Global Child Health Program
-
Cynthia Kapphahn
Clinical Professor, Pediatrics - Adolescent Medicine
Current Research and Scholarly Interests Access to health care services for adolescents.
Confidentiality.
Mental Health Financing.
Eating disorders. -
Mark A. Kay, M.D., Ph.D.
Dennis Farrey Family Professor in Pediatrics, and Professor of Genetics
Current Research and Scholarly Interests Mark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.